Bodyport is a company that develops a biomarker platform intended to detect early signs of cardiovascular disease. It detects cardiac signals and biomarkers through a user's feet, powering algorithms that have the potential to predict risk. The company aims to enable care teams to assess the overall health status of their patients and flag deviations from each patient's individualized health baseline.